CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6074 result(s)

ustekinumab (Stelara/Stelara I.V)

Last Updated: July 9, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New

burosumab (Crysvita)

Last Updated: November 28, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: burosumab
Indications: Treatment of X-Linked Hypophosphatemia

  • Brand Name: Crysvita
  • Manufacturer: Kyowa Kirin Limited
  • Project Number: SR0602-000
  • Project Status: Complete
  • Submission Type: New

Healthy Aging Interventions, Programs, and Initiatives: An Environmental Scan

Last Updated: July 10, 2020
Result type: Reports
Product Line: Environmental Scans
opens in document viewer

Summary Canadians are generally living longer in good health than previous generations. However, there is still a high risk of frailty among community-dwelling older adults. With the older adult population steadily rising in Canada, it is important that effective interventions, programs, and initiatives are developed to support the healthy ag...

  • Project Number: ES0342-000

sacubitril/valsartan (Entresto)

Last Updated: July 2, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: sacubitril/valsartan
Indications: Heart failure, NYHA Class II or III

  • Brand Name: Entresto
  • Manufacturer: Novartis Pharma Inc.
  • Project Number: SR0644-000
  • Project Status: Active
  • Submission Type: Resubmission

icosapent ethyl (Vascepa)

Last Updated: July 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: icosapent ethyl
Indications: Ischemic events in statin-treated patients

  • Brand Name: Vascepa
  • Manufacturer: HLS Therapeutics
  • Project Number: SR0619-000
  • Project Status: Active
  • Submission Type: New

New at CADTH - July 2020

Last Updated: July 8, 2020
Result type: Reports
Product Line: New at CADTH

News and Events CADTH is proud to announce that Suzanne McGurn has officially started her role as the new President and Chief Executive Officer of CADTH. Ms. McGurn was appointed by the CADTH Board of Directors after a comprehensive search that was international in scope. She brings to CADTH significant leadership experience and a deep und...